Endothelial progenitor cells display clonal restriction in multiple myeloma

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Braunstein, Marc ^a,c   Özçelik, Tayfun ^b   Baǧişlar, Sevgi ^b   Vakil, Varsha ^a,c   Smith, Eric L P ^a,c   Dai, Kezhi ^a,c   Akyerli, Cemaliye B ^b   Batuman, Olcay A ^a,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b BILKENT UNIVERSITY   (Turkey)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; AGING; ALLELE; ARTICLE; B LYMPHOCYTE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC LINKAGE; HAIR ROOT; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; STEM CELL; TUMOR CELL; TUMOR VASCULARIZATION; UPREGULATION; X CHROMOSOME INACTIVATION;

AGE FACTORS; CLONE CELLS; ENDOTHELIAL CELLS; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MULTIPLE MYELOMA; MULTIPOTENT STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, ANDROGEN; X CHROMOSOME INACTIVATION;

EID: 33748328395     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-161     Document Type: Article

References (42)

1. Anderson KC: Moving disease biology from the lab to the clinic. Cancer 2003, 97:796-801.
2. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F: Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994, 87:503-508.
3. Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR: Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 2002, 8:2210-2216.
4. Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F, Viale G: Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol 2002, 118:817-820.
5. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F: Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999, 93:3064-3073.
6. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J: Treatment of multiple myeloma. Blood 2004, 103:20-32.
7. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F: Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001, 97:3658-3661.
8. de Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA: Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res 2001, 61:7654-7659.
9. Zhang H, Vakil V, Braunstein M, Smith EL, Maroney J, Chen L, Dai K, Berenson JR, Hussain MM, Klueppelberg U, Norin AJ, Akman HO, Ozcelik T, Batuman OA: Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005, 105:3286-3294.
10. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
11. Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
12. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP: Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
13. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201.
14. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD, Orkin SH: Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 1987, 47:4806-4813.
15. Lyon MF: Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 1962, 14:135-148.
16. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992, 51:1229-1239.
17. Jacobson JL, Hussein MA, Barlogie B, Durie BG, Crowley JJ: A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Br J Haematol 2003, 122:441-450.
18. Durie BG, Salmon SE: Cellular kinetics staging, and immunoglobulin synthesis in multiple myeloma. Annu Rev Med 1975, 26:283-288.
19. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J: International staging system for multiple myeloma. J Clin Oncol 2005, 23:3412-3420.
20. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
21. Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, Birlik AM, Calguneri M, Ozcelik T: Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
22. Deane M, Norton JD: Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol 1990, 20:2209-2217.
23. Gerard CJ, Arboleda MJ, Solar G, Mule JJ, Kerr WG: A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. Hum Gene Ther 1996, 7:343-354.
24. McLeod RS, Zhao Y, Selby SL, Westerlund J, Yao Z: Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins. J Biol Chem 1994, 269:2852-2862.
25. Donovan JW, Ladetto M, Zou G, Neuberg D, Poor C, Bowers D, Gribben JG: Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 2000, 95:2651-2658.
26. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ: Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003, 17:1013-1034.
27. Sangha KK, Stephenson MD, Brown CJ, Robinson WP: Extremely skewed X-chromosome inactivation is increased in women with recurrent spontaneous abortion. Am J Hum Genet 1999, 65:913-917.
28. Brown CJ: Skewed X-chromosome inactivation: cause or consequence? J Natl Cancer Inst 1999, 91:304-305.
29. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JDJ, Stewart AK, Avet-Loiseau H: Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004, 64:1546-1558.
30. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci U S A 1996, 93:13931-13936.
31. Malynn BA, Berman JE, Yancopoulos GD, Bona CA, Alt FW: Expression of the immunoglobulin heavy-chain variable gene repertoire. Curr Top Microbiol Immunol 1987, 135:75-94.
32. Rigolin GM, Fraulini C, Ciccone M, Mauro E, Bugli AM, De Angeli C, Negrini M, Cuneo A, Castoldi G: Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 2005.
33. Palumbo A, Battaglio S, Astolfi M, Frieri R, Boccadoro M, Pileri A: Multiple independent immunoglobulin class-switch recombinations occurring within the same clone in myeloma. Br J Haematol 1992, 82:676-680.
34. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, Gastl G: Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000, 355:1688-1691.
35. Streubel B, Chott A, Huber D, Exner M, Jager U, Wagner O, Schwarzinger I: Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 2004, 351:250-259.
36. Kristiansen M, Langerod A, Knudsen GP, Weber BL, Borresen-Dale AL, Orstavik KH: High frequency of skewed X inactivation in young breast cancer patients. J Med Genet 2002, 39:30-33.
37. Klueppelberg U, Shapira I, Chen LB, Aloba M, Smith E, Palanisamy N, Schmidt J, Moezi M, Batuman O: Long-term treatment of newly diagnosed multiple myeloma with low-dose thalidomide, dexamethasone and zoledronate (TDZ). J Clin Oncol 2005, 23:608S(A).
38. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM: Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002, 109:337-346.
39. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ: Characterization of clonogenic multiple myeloma cells. Blood 2004, 103:2332-2336.
40. Podar K, Anderson KC: The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005, 105:1383-1395.
41. Kumar S, Witzig TE, Dispenzieri A, Lacy MQ, Wellik LE, Fonseca R, Lust JA, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV: Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia 2004, 18:624-627.
42. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico B, Gernone A, Battelli F, Tabilio A, Guidolin D, Petrucci MT, Ribatti D, Dammacco F: Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 2003, 102:3340-3348.